An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer‘s disease—A cohort study of 95,442 individuals
- 19 September 2018
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 14 (12) , 1589-1601
Abstract
Introduction: We tested the hypothesis that low plasma complement C3 is observationally and genetically associated with high risk of Alzheimer's disease (AD).Methods: We studied 95,442 individuals enrolled in the Copenhagen General Population Study. In genetic analyses, we further included 8367 individuals from the Copenhagen City Heart Study. In the two studies, 1189 and 35 developed AD during median 8 years follow‐up.Results: The multifactorially adjusted hazard ratio for risk of AD for a one standard deviation lower levels of complement C3 was 1.11 (95% confidence interval: 1.04–1.19) in all individuals and 1.66 (1.33–2.07) in APOE ε44 carriers. In Mendelian randomization, the corresponding genetic estimates were 1.66 (1.05–2.63) overall and 1.99 (0.52–7.65) in APOE ε44 carriers.Discussion: Low baseline levels of complement C3 were associated with high risk of AD. The risk was amplified in APOE ε44 highly susceptible individuals, and these findings were substantiated by a Mendelian randomization approach, potentially implying causality. Based on these findings, we present and thoroughly discuss an updated Alzheimer hypothesis incorporating low complement C3 levels.Keywords
Funding Information
- Gentofte Hospital
This publication has 70 references indexed in Scilit:
- Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent MannerNeuron, 2012
- A coding variant in CR1 interacts with APOE-ɛ4 to influence cognitive declineHuman Molecular Genetics, 2012
- Complement C3: an emerging risk factor in cardiometabolic diseaseDiabetologia, 2012
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical LiteratureCold Spring Harbor Perspectives in Medicine, 2011
- Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer DiseaseJournal of Biological Chemistry, 2011
- Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE GenotypesArchives of Neurology, 2010
- Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: A potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's diseaseMicrovascular Research, 2008
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991